Skip to main content

Advertisement

Fig. 4 | Clinical Epigenetics

Fig. 4

From: Analysis of the clinical significance of DNA methylation in gastric cancer based on a genome-wide high-resolution array

Fig. 4

Survival curves of stage III GC patients according to the number of hypermethylated genes. a Five-year OS rates: a trend of a worse 5-year OS rates was observed in patients with two or three hypermethylated genes than in those with one or no hypermethylated genes. b Five-year DFS rates: patients with two or three hypermethylated genes had significantly worse 5-year DFS rates than those with one or no hypermethylated genes

Back to article page